4//SEC Filing
Gault Cheryl 4
Accession 0000950170-24-071540
CIK 0002012593other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:43 PM ET
Size
5.4 KB
Accession
0000950170-24-071540
Insider Transaction Report
Form 4
Gault Cheryl
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-06+88,442→ 88,442 totalExercise: $17.00Exp: 2034-06-05→ Common Stock (88,442 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0001839046
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:43 PM ET
- Size
- 5.4 KB